Finland· FI-REL-REL9552

Fortovase

A saquinavir product containing saquinavir, registered in Finland by Roche Registration Limited. The same ATC class is registered in 6 of our 19 countries.

ATC J05AE01

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedFortovaseATCJ05AE01REGISTER NO.FI-REL-REL9552PACKS LISTED0CHECKEDSeptember 27, 2026

Where it is registered

Saquinavir is registered in 6 of 19 countries.

Countries holding a registration under ATC J05AE01 (saquinavir), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 4 of them publish a price we can compare per daily dose

Saquinavir · ATC J05AE01

6 / 19 countries

  • Belgiumprice
  • Denmark
  • Finlandprice
  • Polandprice
  • Spainprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Fimea (Finland)
Active substance
Saquinavir
Manufacturer
Roche Registration Limited
Country
Finland (FI)
ATC code
J05AE01
ATC class
Saquinavir
Defined daily dose
2 g, O
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

470 interactions on record for saquinavir.

Graded by severity as the source publishes them — 215 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Saquinavir · interactions on record

470 records

  • 215 severe
  • 199 moderate
  • 9 minor
  • 29 info

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • OndansetronA04AA01severe
  • GranisetronA04AA02severe

18 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e345c980-8df4-44e3-bd3b-4dcb42a165a0
GET /v1/drugs/e345c980-8df4-44e3-bd3b-4dcb42a165a0?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "1.8",
  "form": "kapseli, pehmeä",
  "route": null,
  "ddd_unit": "g",
  "strength": "200 mg",
  "atc_label": "sakinaviiri",
  "ma_number": null,
  "auth_status": "Myyntilupa peruuntunut",
  "eu_ma_number": "EU/1/98/075/001-002",
  "fimea_rel_id": "REL9552",
  "authorised_at": "1998-08-20"
}

See everything about saquinavir.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.